PLCL1 anticorps (AA 110-350)

N° du produit ABIN7269343

Détail du produit anti-PLCL1 anticorps

Antigène: PLCL1 (phospholipase C-Like 1 (PLCL1))

Épitope: AA 110-350

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PLCL1 est non-conjugé

Application: Western Blotting (WB)

Fonction: PLCL1 Rabbit pAb

Séquence: DCISFMQAGC ELKKVRPNSR IYNRFFTLDT DLQALRWEPS KKDLEKAKLD ISAIKEIRLG KNTETFRNNG LADQICEDCA FSILHGENYE SLDLVANSAD VANIWVSGLR YLVSRSKQPL DFMEGNQNTP RFMWLKTVFE AADVDGNGIM LEDTSVELIK QLNPTLKEAK IRLKFKEIQK SKEKLTTRVT EEEFCEAFCE LCTRPEVYFL LVQISKNKEY LDANDLMLFL EAEQGVTHIT E

Réactivité croisée: Souris, Rat

Attributs du produit: Polyclonal Antibodies

Purification: Affinity purification

Immunogène: Recombinant fusion protein containing a sequence corresponding to amino acids 110-350 of human PLCL1 (NP_006217.3).

Isotype: IgG

Information d'application

Indications d'application: WB,1:200 - 1:2000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur PLCL1

Antigène: PLCL1 (phospholipase C-Like 1 (PLCL1))

Autre désignation: PLCL1 (PLCL1 Produits)

Synonymes: anticorps PLCE, anticorps PLCL, anticorps PLDL1, anticorps PRIP, anticorps C230017K02Rik, anticorps PLC-L, anticorps PLC-L1, anticorps PRIP-1, anticorps phospholipase C like 1 (inactive), anticorps phospholipase C-like 1, anticorps PLCL1, anticorps Plcl1

Sujet: Involved in an inositol phospholipid-based intracellular signaling cascade. Shows no PLC activity to phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol. Component in the phospho-dependent endocytosis process of GABA A receptor (By similarity. Regulates the turnover of receptors and thus contributes to the maintenance of GABA-mediated synaptic inhibition. Its aberrant expression could contribute to the genesis and progression of lung carcinoma. Acts as an inhibitor of PPP1C.,PLCL1,PLCE,PLCL,PLDL1,PPP1R127,PRIP,Signal Transduction,PLCL1

Poids moléculaire: 113kDa/122kDa

ID gène: 5334

UniProt: Q15111